Statins and COVID-19: Effects of Treatment on Patient OutcomesÂ
In an attempt to discover efficacious and safe treatments for COVID-19, the scientific community has been repurposing existing medications with proven track records. One of these established medication classes is statins – which have an excellent record as safe and affordable therapies. Ongoing research is examining the broader use of statins in COVID-19 patients with […]
The Economic Burden of Cardiovascular Disease
Despite the extensive literature and research that indicates the preventability of cardiovascular disease, it remains a primary and leading cause of not only mortality & morbidity, but also a tremendous health care cost and economic burden. A Vital Signs report recently released by the Centers for Disease Control and Prevention cited that in 2016 alone, […]
Stopping Cholesterol-Lowering Drugs Could be Deadly
A new study confirms that stopping a cholesterol-lowering drug can be critically dangerous. Researchers found that people who stopped taking statins, after reporting a side effect, were 13% more likely to die, or have a hear attack or stroke over the next four years. Statins work by inhibiting the liver’s ability to produce cholesterol, while […]
Mixed Reviews on New Statin Guidelines
Statins, a class of lipid-lowering medications that are used in the treatment of high cholesterol, rank in the leagues of the best-selling drugs in the United States: a 2011 study showed that at least 32 million Americans were taking them. While most evidence has demonstrated the efficacy of statins in preventing heart disease in those […]
